MAP2K7 and neuroblastoma: Phosphopeptides from the transcription factor c-Myc, an end-target of both PI3K/Akt/mTor and Raf/MEK/ERK signaling were elevated in the neuroblastoma cell line as well (Figures 3 and 4).